The Indian healthcare sector supports a recent government regulation demanding that hospitals publicly list prices for all medical services. This policy seeks to enhance transparency, accountability, and patient trust by ensuring patients receive upfront details on consultation fees, diagnostic tests, and treatment costs.
Apollo Hospitals expressed strong approval of the new measure, framing it as a critical advancement for patient empowerment. “We welcome the government’s emphasis on greater transparency in healthcare pricing. Easy access to tariff information empowers patients to make informed decisions and plan their treatment journey with greater confidence,” the hospital network said in a statement. Apollo has already implemented its own cost-disclosure system, offering structured fee estimates and pre-treatment counseling to align with the government’s transparency goals.
Faisal Siddiqui, vice president of Cancer Treatment Services International (CTSI) and the American Oncology Institute (AOI), reinforced this view. At AOI, the clinic has long prioritized clear cost communication, ensuring patients fully grasp financial obligations alongside treatment plans while reinforcing the institute’s commitment to ethical practice. “We welcome the Government of India’s initiative to strengthen transparency in healthcare pricing. The ministry of health and family welfare’s communication to States and Union Territories, encouraging the effective implementation of requirements for displaying service rates, is a positive step towards enhancing patient awareness, building trust, and enabling informed decision-making,” he said.
Read Also: FDA approves HIV drug for newborns weighing 2 kg
Smaller and mid-sized hospitals, speaking on condition of anonymity, confirmed that transparency is now a non-negotiable expectation in healthcare. They highlighted that the regulation, covering both medicine costs and procedure fees, will prevent hidden pricing and expand affordable care options for lower-income patients.
Industry leaders acknowledge that while pricing transparency is essential, it must be integrated carefully to avoid disrupting patient care. They stress that clear cost information should not replace clinical judgment but instead work alongside it. The goal remains reducing patient confusion while maintaining service quality and continuity.
